Journal article icon

Journal article

Are phosphodiesterase type 5 inhibitors potential therapies for Alzheimer’s Disease and related dementias?

Abstract:
This scientific commentary refers to ‘No association between initiation of phosphodiesterase-5 inhibitors and risk of incident Alzheimer’s disease and related dementia: results from the Drug Repurposing for Effective Alzheimer’s Medicines (DREAM) study’ by Desai et al. (https://doi.org/10.1093/braincomms/fcac247) in Brain Communications.
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Files:
Publisher copy:
10.1093/braincomms/fcac260

Authors


More by this author
Institution:
University of Oxford
Division:
MSD
Department:
NDORMS
Sub department:
Centre for Statistics in Medicine
Role:
Author
Publisher:
Oxford University Press
Journal:
Brain Communications More from this journal
Volume:
4
Issue:
5
Article number:
fcac260
Publication date:
2022-10-11
Acceptance date:
2022-10-02
DOI:
EISSN:
2632-1297
Language:
English
Keywords:
Pubs id:
1280585
Local pid:
pubs:1280585
Deposit date:
2022-10-03

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP